Viewing Study NCT01630967

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:43 AM
Ignite Modification Date: 2026-02-24 @ 2:30 PM
Study NCT ID: NCT01630967
Status: UNKNOWN
Last Update Posted: 2012-06-28
First Post: 2012-06-25
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)
Sponsor: British Columbia Cancer Agency
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Prostate Neoplasm View
Keywords:

Keywords

Keyword Brief Keyword Text View
None castrate resistance View
None PSA progression View
None LHRH antagonism View